How many shares of AXSM does GLENMEDE TRUST CO NA own?

As of 2026-Q2, GLENMEDE TRUST CO NA holds 942 shares of AXSM (AXSOME THERAPEUTICS INC).

What is GLENMEDE TRUST CO NA's AXSM position worth?

As of 2026-Q2, GLENMEDE TRUST CO NA's AXSM position is worth $230,573.

In 2026-Q2, GLENMEDE TRUST CO NA decreased their AXSM position (-86.0% change in shares).

Based on available 13F filings, GLENMEDE TRUST CO NA first reported a position in AXSM in 2019-Q2. They have held the position across 27 quarters.

Position history for GLENMEDE TRUST CO NA's holdings in AXSOME THERAPEUTICS INC

Current Value

$230,573

Current Shares

942

Total Value Change

+$141,573

Total Shares Change

-2,518

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	942	-86.0%	$230,573	0.0%	$244.77	0
2026-Q1	Decreased	6,716	-3.0%	$1.1M	0.0%	$164.05	0
2025-Q4	Decreased	6,924	-9.0%	$1.3M	0.0%	$148.79	0
2025-Q1	Increased	7,607	+39.2%	$887,204	0.0%	$118.53	33
2024-Q4	Decreased	5,466	-26.9%	$462,478	0.0%	$84.78	0
2024-Q3	Increased	7,473	+0.9%	$671,598	0.0%	$89.64	25
2024-Q2	Increased	7,403	+1.4%	$595,941	0.0%	$80.50	25
2024-Q1	Decreased	7,302	-0.9%	$582,699	0.0%	$79.80	0
2023-Q4	Decreased	7,365	-10.2%	$586,180	0.0%	$79.59	0
2023-Q3	Increased	8,203	+96.6%	$573,307	0.0%	$69.89	39
2023-Q2	Unchanged	4,172	0.0%	$257,328	0.0%	$73.12	0
2023-Q1	Decreased	4,172	-36.4%	$257,328	0.0%	$60.55	0
2022-Q4	Decreased	6,562	-57.8%	$506,127	0.0%	$77.13	0
2022-Q3	Increased	15,561	+173.7%	$694,000	0.0%	$44.15	40
2022-Q2	New	5,685	-	$217,000	0.0%	$36.49	32
2022-Q1	Exited	0	-100.0%	$0	0.0%	$40.02	0
2021-Q4	New	5,535	-	$209,000	0.0%	$38.02	32
2021-Q3	Exited	0	-100.0%	$0	0.0%	$34.17	0
2021-Q2	Decreased	5,500	-4.1%	$371,000	0.0%	$69.66	0
2021-Q1	Increased	5,735	+1.1%	$324,000	0.0%	$55.91	24
2020-Q4	Increased	5,675	+11.0%	$462,000	0.0%	$83.26	27
2020-Q3	Increased	5,113	+94.2%	$364,000	0.0%	$72.28	38
2020-Q2	Decreased	2,633	-48.4%	$216,000	0.0%	$76.36	0
2020-Q1	Unchanged	5,106	0.0%	$527,000	0.0%	$57.58	0
2019-Q4	Decreased	5,106	-15.0%	$527,000	0.0%	$103.83	0
2019-Q3	Increased	6,005	+73.5%	$121,000	0.0%	$22.09	33
2019-Q2	New	3,460	-	$89,000	0.0%	$25.75	30